Since its creation in 2017, hystrix has consistently pursued its vision to make the procurement and distribution of medical products simpler, faster and more cost-effective by creating a digital marketplace that intends to function not only as a platform for medical goods trading, but also as a real-time information hub for large sections of the healthcare industry.
Headquartered in the canton of Bern, the company has successfully completed a CHF 3 million Series A financing round. Hirslanden Venture Capital AG, a subsidiary of Mediclinic International and the Steyn Group, a global investor with a legacy in online marketplaces, led the investor group.
Further development of functionalities and internationalization
The recently concluded financing round will be used to further develop strategic marketplace functionalities, support ongoing ERP integration projects, expand the user base and the corresponding product portfolios, as well as further internationalize the business model developed in Switzerland. The company received a grant, as part of the European Union "Horizon 2020" programme, to conduct a European feasibility study of the digital marketplace.
Philippe Hügli, CEO and founder, is pleased that hystrix is increasingly seen as a pioneer in the industry. "We help suppliers adapt their distribution cost structure to today's conditions and optimize their relationships with hospital customers. On the other hand, we offer hospitals an efficient and time-saving "one-stop shop" for comparing prices and procuring consumables from different vendors”, he commented. More than 120 hospitals in Switzerland are currently using the hystrix marketplace.
